KERENDIA (finerenone)

Bayer Pharmaceuticals, Inc.

Kerendia (finerenone) is a once-daily tablet that slows the progression of kidney damage and reduce the risk of cardiovascular death, heart attack, and hospitalization for heart failure in adults with chronic kidney disease and type 2 diabetes.


Features


Specs

Drug Class:
Mineralocorticoid receptor antagonist
Cost:
High
Medication Type:
Oral